Yu T, Li W, Yu T
Front Oncol. 2023; 13:1217023.
PMID: 37601670
PMC: 10438954.
DOI: 10.3389/fonc.2023.1217023.
Qi F, Bao M, Gao H, Zhang X, Zhao S, Wang C
Ann Hematol. 2023; 102(10):2707-2716.
PMID: 37578540
DOI: 10.1007/s00277-023-05413-0.
Verweij L, Ector G, Smit Y, van Vlijmen B, van der Reijden B, Hermens R
BMC Health Serv Res. 2023; 23(1):228.
PMID: 36890512
PMC: 9994406.
DOI: 10.1186/s12913-023-09153-9.
Kim C, Kim J, Choi D
Blood Res. 2022; 57(1):74-75.
PMID: 35342044
PMC: 8958368.
DOI: 10.5045/br.2022.2021146.
Breccia M, Abruzzese E, Accurso V, Attolico I, Barulli S, Bergamaschi M
Br J Haematol. 2021; 196(3):559-565.
PMID: 34636033
PMC: 8652631.
DOI: 10.1111/bjh.17890.
Chronic Myeloid Leukemia in Children: Immune Function and Vaccinations.
Suttorp M, Webster Carrion A, Hijiya N
J Clin Med. 2021; 10(18).
PMID: 34575167
PMC: 8470625.
DOI: 10.3390/jcm10184056.
The serological prevalence of SARS-CoV-2 infection in patients with chronic myeloid leukemia is similar to that in the general population.
Bonifacio M, Tiribelli M, Miggiano M, Abruzzese E, Binotto G, Scaffidi L
Cancer Med. 2021; 10(18):6310-6316.
PMID: 34464516
PMC: 8446554.
DOI: 10.1002/cam4.4179.
The Care of the Leukemic Patients in Times of SARS-CoV-2.
Karki N, Le T, Cortes J
Curr Oncol Rep. 2021; 23(10):114.
PMID: 34342734
PMC: 8330191.
DOI: 10.1007/s11912-021-01111-0.
Mental Health in Persons With Chronic Myeloid Leukemia During the SARS-CoV-2 Pandemic: The Need for Increased Access to Health Care Services.
Bao M, Yang S, Gale R, Zhang Y, Liu X, Zhu H
Front Psychiatry. 2021; 12:679932.
PMID: 34168583
PMC: 8217438.
DOI: 10.3389/fpsyt.2021.679932.
COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statement.
McCaughan G, Di Ciaccio P, Ananda-Rajah M, Gilroy N, MacIntyre R, Teh B
Intern Med J. 2021; 51(5):763-768.
PMID: 34047035
PMC: 8206846.
DOI: 10.1111/imj.15247.
Treating Acute Leukemia During the COVID-19 Pandemic in an Environment With Limited Resources: A Multicenter Experience in Four Latin American Countries.
Demichelis-Gomez R, Alvarado-Ibarra M, Vasquez-Chavez J, Delgado-Lopez N, Gomez-Cortes C, Espinosa-Bautista K
JCO Glob Oncol. 2021; 7:577-584.
PMID: 33891480
PMC: 8162972.
DOI: 10.1200/GO.20.00620.
Weathering the storm: COVID-19 infection in patients with hematological malignancies.
Wang L, Su Yin E, Wei G, Hu Y, Nagler A, Huang H
J Zhejiang Univ Sci B. 2021; 21(12):921-939.
PMID: 33843158
PMC: 7759451.
DOI: 10.1631/jzus.B2000423.
COVID-19-Induced Pancytopenia in a Major Molecular Response CML Patient on Dasatinib: A Case Report and Review of the Literature.
Singh B, Ayad S, Kaur P, Kumar V, Gupta S, Maroules M
Eur J Case Rep Intern Med. 2021; 8(1):002233.
PMID: 33585346
PMC: 7875585.
DOI: 10.12890/2021_002233.
A comprehensive drug repurposing study for COVID19 treatment: novel putative dihydroorotate dehydrogenase inhibitors show association to serotonin-dopamine receptors.
Berber B, Doluca O
Brief Bioinform. 2021; 22(2):1023-1037.
PMID: 33406218
PMC: 7929379.
DOI: 10.1093/bib/bbaa379.
COVID-19 in Chronic-Phase Chronic Myeloid Leukemia Patients: A Single-Center Survey from Turkey.
Yilmaz U, Pekmezci A, Gul Y, Eskazan A
Turk J Haematol. 2020; 38(1):79-81.
PMID: 32964857
PMC: 7927441.
DOI: 10.4274/tjh.galenos.2020.2020.0472.
